Lipocine Inc.LPCNNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P14
Within normal range
vs 2Y Ago
-348.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-644.34%
202488.96%
20231.85%
2022-173.88%
202171.12%
2020-31.17%
20193.42%
201827.68%
20178.94%
2016-19.22%